Earnings History Data for Liminal BioSciences Inc. (LMNL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Liminal BioSciences Inc.

Liminal BioSciences Inc. is a biotechnology company. It engages in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. The company's product pipeline consists of PBI-4050, which are in clinical stage. Liminal BioSciences Inc., formerly known as Prometic Life Sciences Inc., is based in Laval, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-11-2022 AH 5:05 PM ET
(Nov 9)
LMNL Liminal BioSciences Inc. 15.37 -0.11 0.00 -0.26 Liminal BioSciences reports Q3 results
[11/9/2022 5:12 PM]
0.4840 -0.01 
(-2.22%)
0.0 0.0 
(0.00%)
0.37 - 1.68 21,934 10,000 0
17-05-2021 AH 4:40 PM ET
(May 17)
LMNL Liminal Biosciences Inc. 124.00 -0.52 -0.50 0.00 Liminal BioSciences reports Q1 results
[5/17/2021 4:46 PM]
4.25 -0.19 
(-4.28%)
4.26 -0.18 
(-4.05%)
3.51 - 31.45 310,197 340,000 10,267
12-11-2020 AH LMNL Liminal BioSciences Inc. 94.75 -0.74 -0.76 -0.96 Liminal BioSciences beats on revenue
[11/12/2020 5:03 PM]
3.66 -0.46 
(-11.16%)
3.90 -0.22 
(-5.34%)
3.51 - 31.45 1,768,207 814,812 91,977